Skip Navigation

On September 1, 2009, the CRISP system will be retired - The CRISP system will soon be replaced by the RePORT Expenditures and Results (RePORTER) query tool.
more...

Swine Flu Info

Home > RCDC

Open House Webcast: The archive of the January 14, 2009 RCDC Open House Meeting webcast is now available.

The Research, Condition, and Disease Categorization Process

The National Institutes of Health (NIH) is the Nation’s medical research agency. Funded by U.S. tax dollars, the NIH supports researchers throughout the country and around the world as they work to improve people’s health.

The NIH recognizes the importance of keeping the American people informed about how their tax dollars are spent to support medical research. To enhance public accessibility to reports, data, and analyses of NIH research activities, the Research Portfolio Online Reporting Tool (RePORT) website gives the public a single access point to quickly and easily find data, including information on NIH expenditures and the results of NIH-supported research.

In January 2009, the NIH added the new Research, Condition, and Disease Categorization (RCDC) reports to the RePORT site. RCDC is a computerized process the NIH uses at the end of each fiscal year to sort and report the amount it funded in each of 215 historically reported categories of disease, condition, or research area.

RCDC provides consistent and transparent information to the public about NIH-funded research. For the first time, a complete list of all NIH-funded projects related to each category is available. By clicking on each of the categories, the public can access full project listings for that category and view, print, or download the detailed report.

Some of the funding amounts that RCDC reports might differ from NIH reports issued in the past. The reason for the difference is that RCDC is sorting funded research using a new method. The way the NIH budgets and spends tax dollars throughout the year stays the same.

Download Readers:

We would like to hear from you. Click here to provide your feedback

| | | | | | | |
| | | | |